significantly more common in PXE patients in the intracranial internal carotid artery (75% vs 44%), the arteries of the arms (20% vs 3%), the femoral-popliteal arteries (74% vs 44%), and the infrapopliteal arteries (84% vs 38%). In these arteries, calcification scores also indicated more severe calcification. Severe calcification was significantly more prevalent in PXE patients compared to controls in the internal intracranial carotid artery (36% vs 19%; P < .001), femoral-popliteal arteries (51% vs 31%; P < .001), and infrapopliteal arteries (61% vs 24%; P < .001). In the hospital controls, significant more severe calcification was observed for the thoracic aorta, the mesenteric arteries, and the external iliac arteries. No significant differences in prevalence of arterial calcification were observed in other arterial beds, such as the coronary arteries (45% vs 43%; P ¼ .776), the carotid arteries (52% vs 46%; P ¼ .476), and the abdominal aorta (71% vs 63%; P ¼ .287). Subgroup analyses of patients younger than 55 years only showed similar differences in prevalence of arterial calcifications between PXE patients and controls, with most pronounced calcifications in the arteries of the lower legs (67% vs 8%). Similar patterns were observed in those without concomitant diabetes or renal dysfunction.
Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force
Chou R, Dana T, Blazina I, Daeges M, Jeanne TL. JAMA 2016; 316:2008-24 .
Conclusions: In adults without prior cardiovascular events but at increased cardiovascular disease (CVD) risk, statin therapy is associated with reduced risk of all-cause and cardiovascular mortality and CVD events, with greater absolute benefits in patients at greater baseline risk.
Summary: The objective of this study was to review systematically the benefits and harm of statins for the prevention of CVD by selecting and analyzing the results of randomized controlled trials of statins versus placebo, fixed-dose, or titrated, and higher-versus lower-intensity statins in adults without prior cardiovascular events. After appropriate selection, the data were pooled using random-effects meta-analysis with the main outcomes being all-cause mortality, CVD-related morbidity and mortality, and associated harm. A detailed description of the method of trial selection is included in the text. All trials enrolled patients with increased cardiovascular risk (dyslipidemia, diabetes, hypertension, aortic stenosis, microalbuminuria, and elevated C-reactive protein levels, elevated waist-to-hip ratio, mild renal failure, among others). Nineteen trials were found that compared statins versus placebo or no statin (n ¼ 71,344 participants; range, 95-17,802; mean age, 51-66 years Conclusions: Self-made bovine pericardial tube grafts can be crafted to almost any size and adjusted to complex anatomic requirements. It appears resistant to reinfection and demonstrated good patency in nine patients.
Summary: This study is a retrospective analysis of nine patients with bovine fashioned grafts and 10 patients with miscellaneous grafts (vein, homograft) used to treat vascular graft infections. During a 5-year period , 19 patients required reconstruction for a primary (n ¼ 11) or prosthetic graft (n ¼ 8) infection. Demographics were consistent with a male population averaging 59.6 year of age. Two patients required two peripheral operations. There were eight in situ thoracic/aortic reconstructions and 13 peripheral reconstructions. Bacteria present were Staphylococci (n ¼ 7), Streptococci (n ¼ 5), Enterococci (n ¼ 3), Gram-negative (n ¼ 7; Salmonella, E. coli, Serratia, Camphylobacter, Klebsiella pneumonia), and Candida (n ¼ 1). The xenograft was used in two central and seven peripheral locations, while homograft was used in 2 central, femoral vein in 4 central and 4 peripheral and saphenous vein in 2 peripheral cases. The patients were followed with computed tomography angiography at 3, 6, and 12 months, and then yearly per report. The graft repair was in addition to wide debridement and antibiotics. The mean followup was 17 months for the xenograft patients and 45 months the miscellaneous group. The Kaplan-Meier method was used to present results and demonstrated (at 12 months) in both groups an infection-free rate of 100% and patency rate of 100% when two early deaths in the miscellaneous group were excluded. These deaths occurred in two patients reconstructed with an aortobi-iliac homograft to replace an infected synthetic graft but who experienced continued sepsis with multisystem organ failure (overall in-hospital mortality, 10.5%). Nine patients (47.4%) experienced complications, of which five were minor (seroma/wound healing treated surgically) and four major (2 bleeding, 1 hemothorax, 1 acute femoral vein aortobi-iliac graft occlusion). The xenograft material had two complications (22.2%; hemothorax and lymphatic fistula), while the miscellaneous grafts had seven complications (77.8%).
Comments: I found this to be an interesting article since it provides an option when other conduits might not be available. There have been other reports of its use as mentioned in this article's references and a recent report of a hybrid graft (Stather PW, Howard AQ. A novel technique for bifurcated bovine plus Omniflow aortic graft reconstruction. 
Conclusions:
The characteristics of asymptomatic patients with incidentally revealed superior mesenteric artery (SMA) dissection were comparable to symptomatic patients with the exception that symptomatic patients were younger by nearly a decade. In general, medical treatment of symptomatic patients is effective, while those found incidentally require no change in management. Complete remodeling is favored in those with symptoms at presentation and no false lumen flow.
